Kenya Pharmaceutical Industry - Diagnostic Report 2020 : Summary (English)

The Kenya Pharmaceutical Industry Diagnostic Report 2020 highlights and examines gaps, challenges, and opportunities in Kenya’s pharmaceutical industry. The report recommends steps to spur the industry’s growth and make it more competitive.

Document also available in : English

DETAILS

Author

Ndolo, Carolyne;

Sharma,Jatinder K.;

Adeseun, Aderemi;

Ochieng,Sarah Ruth;

Gitau, Njeri;

Moses,Manuel;

Kaestner,Lisa A.;

Twagira,Frank Abner;

Okoth,Leah Nyokabi;

Matama,Everlyne Nancy Anyango;

Munyua,Felister Huro Muchina;

Njoroge,Serah Njere;
Document Date
2020/01/01
Document Type
Report
Report Number
172791
Volume No
1
Country
Kenya,
Region
Eastern and Southern Africa,
Disclosure Date
2022/06/29
Disclosure Status
Disclosed
Doc Name
Kenya Pharmaceutical Industry - Diagnostic Report 2020 : Summary

Citation

Ndolo, Carolyne; Sharma,Jatinder K.; Adeseun, Aderemi; Ochieng,Sarah Ruth; Gitau, Njeri; Moses,Manuel; Kaestner,Lisa A.; Twagira,Frank Abner; Okoth,Leah Nyokabi; Matama,Everlyne Nancy Anyango; Munyua,Felister Huro Muchina; Njoroge,Serah Njere.

Kenya Pharmaceutical Industry - Diagnostic Report 2020 : Summary (English). Washington, D.C. : World Bank Group. http://documents.worldbank.org/curated/en/099120506292212026

Kenya Pharmaceutical Industry - Diagnostic Report 2020 : Summary (English)

DETAILS

Citation

SUBSCRIBE TO EMAIL ALERTS